Hi, Shrewd!        Login  
Shrewd'm.com 
A merry & shrewd investing community
Best Of BRK.ABest OfAll BoardsThe Shrewd’m WeeklyLearn to InvestHow to Become Shrewd
Search
Shrewd'm.com Merry shrewd investors
Search
Best Of BRK.ABest OfAll BoardsThe Shrewd’m WeeklyLearn to InvestHow to Become Shrewd


The week's question
In December 2024, in the thread "Re: BRK: Why Not XOM?", BreckHutHigh asked the members: "What about the long road trips with kids?" This week it is put to everyone again. The button below opens the small thread re-asking it - read what others have said so far, then give your own answer as an ordinary reply.
Answer this questionContinue to Shrewd'mThis note won't appear again
Stocks A to Z / Stocks B / Berkshire Hathaway (BRK.A)
Unthreaded | Threaded | Whole Thread (14) |
Author: mungofitch 🐝🐝🐝 GOLD
SHREWD
  😊 😞

Number: of 21941 
Subject: Re: OT: gain of function research
Date: 06/19/23 10:06 PM
Post New | Post Reply | Report Post | Recommend It!
No. of Recommendations: 12
What possible positive outcomes are there?

I think one main reasoning goes like this: basic research about your enemy is often time very well spent.
There are quite a few pathogens out there that would be extremely bad if they figured out just one or two more tricks.
How to go airborne, for example, or how to attach to human cells. Or related things, like how and when certain families of viruses mix and combine.
Learning how those mutation mechanisms work and combine could help in a lot of ways, for example determining which "not quite there yet" diseases are the biggest risk and might warrant preventative action.

Much of the research is valid, and I believe it can be done safely, given the right care.

That care is not always taken, alas.
It is sadly true that lab leaks are not exactly unheard of, ignoring any discussion of Covid19.

Jim
Post New | Post Reply | Report Post | Recommend It!
Print the post
Members reply directly to mungofitch here — and replies get answered. Reading is free; so is joining the conversation. Join Shrewd'm »
This community has written 21,448 posts about Berkshire Hathaway. The article-length ones it recommended most:
BRK: Why Not XOM? · 62 recs · 2024
Second quarter comments · 60 recs · 2023
Berkshire's Profit Contributors · 57 recs · 2023
Summary of 2Q 2026 · 54 recs · 2026
3Q Summary · 53 recs · 2024
Unthreaded | Threaded | Whole Thread (14) |


Announcements
Berkshire Hathaway FAQ
Contact Shrewd'm
Contact the developer of these message boards.

Best Of BRK.A | Best Of | Favourites & Replies | All Boards | Followed Shrewds | Open Questions | Moving a community